These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 36660722)
21. Potential role of m6A RNA methylation regulators in osteosarcoma and its clinical prognostic value. Liu H; Qin G; Ji Y; Wang X; Bao H; Guan X; Wei A; Cai Z J Orthop Surg Res; 2021 May; 16(1):294. PubMed ID: 33952279 [TBL] [Abstract][Full Text] [Related]
22. m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer. Zhang C; Liu J; Guo H; Hong D; Ji J; Zhang Q; Guan Q; Ren Q Bioengineered; 2021 Dec; 12(1):3159-3176. PubMed ID: 34187307 [TBL] [Abstract][Full Text] [Related]
23. Comprehensive analyses of m6A RNA methylation patterns and related immune microenvironment in idiopathic pulmonary arterial hypertension. Gao G; Chen A; Gong J; Lin W; Wu W; Mohammad Ismail Hajary S; Lian G; Luo L; Xie L Front Genet; 2023; 14():1222368. PubMed ID: 37732317 [TBL] [Abstract][Full Text] [Related]
24. Expression Pattern and Clinical Value of Key m6A RNA Modification Regulators in Abdominal Aortic Aneurysm. Li T; Wang T; Jing J; Sun L J Inflamm Res; 2021; 14():4245-4258. PubMed ID: 34511965 [TBL] [Abstract][Full Text] [Related]
25. Four m6A RNA Methylation Gene Signatures and Their Prognostic Values in Lung Adenocarcinoma. Wang Y; Zhao X; Li J; Wang X; Hu W; Zhang X Technol Cancer Res Treat; 2022; 21():15330338221085373. PubMed ID: 35343834 [No Abstract] [Full Text] [Related]
26. Construction and validation of prognostic prediction established on N6-methyladenosine related genes in cervical squamous cell carcinoma. Chen D; Guo W; Yu H; Yang J Transl Cancer Res; 2022 Sep; 11(9):3064-3079. PubMed ID: 36237271 [TBL] [Abstract][Full Text] [Related]
27. A new m6A methylation-related gene signature for prognostic value in patient with urothelial carcinoma of the bladder. Zheng B; Wang J; Zhao G; Chen X; Yao Z; Niu Z; He W Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33779704 [TBL] [Abstract][Full Text] [Related]
28. Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer. Xu LC; Pan JX; Pan HD Cancer Manag Res; 2020; 12():5385-5394. PubMed ID: 32753956 [TBL] [Abstract][Full Text] [Related]
29. The functions and prognostic values of m6A RNA methylation regulators in thyroid carcinoma. Yu ZH; Feng ST; Zhang D; Cao XC; Yu Y; Wang X Cancer Cell Int; 2021 Jul; 21(1):385. PubMed ID: 34281544 [TBL] [Abstract][Full Text] [Related]
30. N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non-Small Cell Lung Cancer Prognosis. Zhao Z; Cai Q; Zhang P; He B; Peng X; Tu G; Peng W; Wang L; Yu F; Wang X Front Mol Biosci; 2021; 8():657087. PubMed ID: 34179079 [TBL] [Abstract][Full Text] [Related]
31. Construction of an N6-methyladenosine lncRNA- and immune cell infiltration-related prognostic model in colorectal cancer. Yu ZL; Zhu ZM Protoplasma; 2022 Jul; 259(4):1029-1045. PubMed ID: 34734333 [TBL] [Abstract][Full Text] [Related]
32. Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer. Ji H; Zhang JA; Liu H; Li K; Wang ZW; Zhu X Front Immunol; 2022; 13():976107. PubMed ID: 36091006 [TBL] [Abstract][Full Text] [Related]
33. The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma. Fang Q; Chen H Mol Med; 2020 Jun; 26(1):60. PubMed ID: 32552682 [TBL] [Abstract][Full Text] [Related]
34. Gene Alterations of N6-Methyladenosine (m Zhang Q; Cai Y; Kurbatov V; Khan SA; Lu L; Zhang Y; Johnson CH Biomed Res Int; 2020; 2020():8826456. PubMed ID: 33415160 [TBL] [Abstract][Full Text] [Related]
35. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor. Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069 [TBL] [Abstract][Full Text] [Related]
36. Comprehensive analysis of the expression of N6-methyladenosine RNA methylation regulators in pulmonary artery hypertension. Zheng H; Hua J; Li H; He W; Chen X; Ji Y; Li Q Front Genet; 2022; 13():974740. PubMed ID: 36171892 [No Abstract] [Full Text] [Related]
37. N6-methyladenosine methylation-related genes Wang Y; Li T; Liu H; Liang Y; Wang G; Fu G; Takatsuki M; Qu H; Jing F; Li J; Jiang M Ann Transl Med; 2022 Dec; 10(24):1398. PubMed ID: 36660669 [TBL] [Abstract][Full Text] [Related]
38. Characterization of ligamentum flavum hypertrophy based on m6A RNA methylation modification and the immune microenvironment. He Z; Zhu Z; Tang T; Guo P; Gao M; Li B; Nguyen TCT; Chen H; Liu X; Zhou Z; Liu S Am J Transl Res; 2022; 14(12):8800-8827. PubMed ID: 36628248 [TBL] [Abstract][Full Text] [Related]
39. Molecular characterization of m6A RNA methylation regulators with features of immune dysregulation in IgA nephropathy. Wang Y; Sun N; He R; Wang Z; Jin J; Gao T; Qu J Clin Exp Med; 2024 May; 24(1):92. PubMed ID: 38693353 [TBL] [Abstract][Full Text] [Related]